Cargando…
Using an Interaction Parameter in Model-Based Phase I Trials for Combination Treatments? A Simulation Study
There is growing interest in Phase I dose-finding studies studying several doses of more than one agent simultaneously. A number of combination dose-finding designs were recently proposed to guide escalation/de-escalation decisions during the trials. The majority of these proposals are model-based:...
Autores principales: | Mozgunov, Pavel, Knight, Rochelle, Barnett, Helen, Jaki, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796482/ https://www.ncbi.nlm.nih.gov/pubmed/33466469 http://dx.doi.org/10.3390/ijerph18010345 |
Ejemplares similares
-
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019) -
An information theoretic phase I–II design for molecularly targeted agents that does not require an assumption of monotonicity
por: Mozgunov, Pavel, et al.
Publicado: (2018) -
Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial
por: Mozgunov, Pavel, et al.
Publicado: (2022) -
Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic
por: Ewings, Sean, et al.
Publicado: (2022) -
An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022)